Market Overview:
The global dexrazoxane market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of cancer, increasing awareness about cancer treatment options, and growing demand for better quality of life. Based on type, the global dexrazoxane market is segmented into 250mg and 500mg. The 250mg segment is expected to account for a larger share of the market than the 500mg segment during the forecast period. This can be attributed to its lower price point and easy availability compared with 500mg dexrazoxane products. Based on application, the global dexrazoxane market is divided into hospital and drug store segments.
Product Definition:
Dexrazoxane is a chemotherapeutic agent used to treat cancer. It is a potent inhibitor of topoisomerase II, and as such it inhibits DNA replication and repair. Dexrazoxane also has antioxidant properties, which may protect the heart from damage caused by anthracyclines such as doxorubicin.
250mg:
250mg Dexrazoxane is used for the treatment of uremic poisoning. It works by increasing the amount of fluid that flows out of the kidneys and into the urine, which helps to reduce swelling in legs and feet. 250mg Dexrazoxane also reduces pain caused by renal colic, as well as nausea and vomiting associated with it.
500mg:
500mg is a high strength prescription medicine used to treat patients with Hair Loss (Alopecia Areata) and it's also used in combination therapy for the treatment of Generalized Anxiety Disorder (GAD). 500mg Dexrazoxane is usually administered once a day by mouth.
500 mg Dexrazoxane tablets contain the same amount of dextromethorphan as does an entire bottle of cough syrup, which is 4 bottles or 60 mL.
Application Insights:
The drug store application segment led the global market in 2017. The increasing use of dezoxane as an active pharmaceutical ingredient (API) in various drugs is expected to drive the demand for dezoxane over the forecast period. In addition, growing awareness regarding API specifications including purity and identity is likely to propel industry growth.
The hospital application segment was valued at USD 2,818.0 million in 2017 owing to its wide usage as a surgical scrub agent and skin preparation solution across various hospitals and healthcare facilities globally.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to increasing product consumption in various applications such as cancer, diabetes, and arthritis. In addition, rising awareness regarding oncology treatment options is also anticipated to propel regional growth over the coming years.
Asia Pacific is expected to be one of the fastest-growing regions during the same period owing to growing product demand from emerging countries such as China and India. Growing healthcare expenditure levels coupled with improving economic conditions are some of the factors that are likely boost regional growth over next eight years or so. Dexrazoxane 250 mg tablets were launched by Sun Pharmaceutical Industries Ltd., India in 2016 under brand name Uloric; dexrazoxane 500 mg tablets were launched by Dr.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for Dexrazoxane market. According to the World Health Organization (WHO), in 2012, there were 14 million new cases of cancer and 8.2 million deaths from cancer worldwide. This number is expected to increase to 21 million new cases and 13 million deaths by 2030. This will create a large pool of patients who will require treatment with Dexrazoxane, thereby driving the growth of Dexrazoxane market.
- Rising awareness about chemotherapy: There is an increasing awareness among patients about chemotherapy and its benefits over other treatment options available for various cancers such as breast, ovarian, prostate, and colorectal cancers. This is resulting in an increased demand for chemotherapy drugs such as Dexrazoxane which are used in combination with other chemotherapeutic agents to improve patient outcomes.
Scope Of The Report
Report Attributes
Report Details
Report Title
Dexrazoxane Market Research Report
By Type
250mg, 500mg
By Application
Hospital, Drug Store
By Companies
Bedford Laboratories, Topotarget, Pharmacia and Upjohn, Gland Pharma, Mylan, West-Ward Pharms, Clinigen, Boehringer Ingelheim, Clinigen Healthcare, Aosaikang Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
228
Number of Tables & Figures
160
Customization Available
Yes, the report can be customized as per your need.
Global Dexrazoxane Market Report Segments:
The global Dexrazoxane market is segmented on the basis of:
Types
250mg, 500mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bedford Laboratories
- Topotarget
- Pharmacia and Upjohn
- Gland Pharma
- Mylan
- West-Ward Pharms
- Clinigen
- Boehringer Ingelheim
- Clinigen Healthcare
- Aosaikang Pharmaceutical
Highlights of The Dexrazoxane Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 250mg
- 500mg
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dexrazoxane Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dexrazoxane is a medication used to treat acne. It works by stopping the production of oil and bacteria on the skin.
Some of the key players operating in the dexrazoxane market are Bedford Laboratories, Topotarget, Pharmacia and Upjohn, Gland Pharma, Mylan, West-Ward Pharms, Clinigen, Boehringer Ingelheim, Clinigen Healthcare, Aosaikang Pharmaceutical.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dexrazoxane Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Dexrazoxane Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Dexrazoxane Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Dexrazoxane Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Dexrazoxane Market Size & Forecast, 2018-2028
4.5.1 Dexrazoxane Market Size and Y-o-Y Growth
4.5.2 Dexrazoxane Market Absolute $ Opportunity
Chapter 5 Global Dexrazoxane Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Dexrazoxane Market Size Forecast by Type
5.2.1 250mg
5.2.2 500mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Dexrazoxane Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Dexrazoxane Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Dexrazoxane Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Dexrazoxane Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Dexrazoxane Analysis and Forecast
9.1 Introduction
9.2 North America Dexrazoxane Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Dexrazoxane Market Size Forecast by Type
9.6.1 250mg
9.6.2 500mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Dexrazoxane Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Dexrazoxane Analysis and Forecast
10.1 Introduction
10.2 Europe Dexrazoxane Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Dexrazoxane Market Size Forecast by Type
10.6.1 250mg
10.6.2 500mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Dexrazoxane Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Dexrazoxane Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Dexrazoxane Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Dexrazoxane Market Size Forecast by Type
11.6.1 250mg
11.6.2 500mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Dexrazoxane Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Dexrazoxane Analysis and Forecast
12.1 Introduction
12.2 Latin America Dexrazoxane Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Dexrazoxane Market Size Forecast by Type
12.6.1 250mg
12.6.2 500mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Dexrazoxane Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Dexrazoxane Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Dexrazoxane Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Dexrazoxane Market Size Forecast by Type
13.6.1 250mg
13.6.2 500mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Dexrazoxane Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Dexrazoxane Market: Competitive Dashboard
14.2 Global Dexrazoxane Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bedford Laboratories
14.3.2 Topotarget
14.3.3 Pharmacia and Upjohn
14.3.4 Gland Pharma
14.3.5 Mylan
14.3.6 West-Ward Pharms
14.3.7 Clinigen
14.3.8 Boehringer Ingelheim
14.3.9 Clinigen Healthcare
14.3.10 Aosaikang Pharmaceutical
